메뉴 건너뛰기




Volumn 35, Issue 6, 2011, Pages

Sudden acute leukemia transformation in a MDS patient with del(5q) in complete cytogenetic remission after lenalidomide

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; ERYTHROPOIETIN; LENALIDOMIDE;

EID: 79955607659     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.12.019     Document Type: Letter
Times cited : (4)

References (4)
  • 1
    • 76649129531 scopus 로고    scopus 로고
    • Lenalidomide in myelodysplastic syndromes: an erythropoiesis-stimulating agent or more?
    • Komrokji R.S., Lancet J.E., List A.F. Lenalidomide in myelodysplastic syndromes: an erythropoiesis-stimulating agent or more?. Curr Hematol Malign Rep 2010, 5:9-14.
    • (2010) Curr Hematol Malign Rep , vol.5 , pp. 9-14
    • Komrokji, R.S.1    Lancet, J.E.2    List, A.F.3
  • 2
    • 77649303359 scopus 로고    scopus 로고
    • Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression
    • Gohring G., Giagounidis A., Busche G., Kreipe H.H., Zimmermann M., Hellstrom-Lindberg E., et al. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression. Ann Hematol 2010, 89:365-374.
    • (2010) Ann Hematol , vol.89 , pp. 365-374
    • Gohring, G.1    Giagounidis, A.2    Busche, G.3    Kreipe, H.H.4    Zimmermann, M.5    Hellstrom-Lindberg, E.6
  • 3
    • 33749438404 scopus 로고    scopus 로고
    • Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
    • List A., Dewald G., Bennett J., Giagounidis A., Raza A., Feldman E., et al. Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N Engl J Med 2006, 355:1456-1465.
    • (2006) N Engl J Med , vol.355 , pp. 1456-1465
    • List, A.1    Dewald, G.2    Bennett, J.3    Giagounidis, A.4    Raza, A.5    Feldman, E.6
  • 4
    • 77952430255 scopus 로고    scopus 로고
    • Immunomodulatory drugs in myelodysplastic syndromes: long-term outcome
    • List A.F. Immunomodulatory drugs in myelodysplastic syndromes: long-term outcome. Hematol Educ 2008, 2:91-94.
    • (2008) Hematol Educ , vol.2 , pp. 91-94
    • List, A.F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.